Search research articles
Contact Us
Filters
Showing results (161-170 of 194) with videos related to
Page
of 20
Sort By:
Journal of Cutaneous Pathology
|
June 30, 2019
Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features
Michael T Tetzlaff, Sherry Tang, Taylor Duke, et al.
Cancers
|
November 6, 2019
Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity
Haider A Mejbel, Sri Krishna C Arudra, Dinesh Pradhan, et al.
Cancer
|
December 20, 2011
NRAS mutation status is an independent prognostic factor in metastatic melanoma
John A Jakob, Roland L Bassett, Chaan S Ng, et al.
Journal of Cutaneous Pathology
|
October 8, 2021
Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy
Riyad N H Seervai, Woo Cheal Cho, Emily Y Chu, et al.
Journal of Cutaneous Pathology
|
December 10, 2021
Severe de novo pustular psoriasiform immune-related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma
Riyad N H Seervai, Meghan Heberton, Woo Cheal Cho, et al.
Journal of Cutaneous Pathology
|
May 13, 2020
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma
Mario L Marques-Piubelli, Michael T Tetzlaff, Priyadharsini Nagarajan, et al.
Journal of Cutaneous Pathology
|
June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions
Wei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
Cells
|
March 13, 2024
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides
Mario L Marques-Piubelli, Jesus Navarrete, Debora A Ledesma, et al.
The American Journal of Dermatopathology
|
May 8, 2024
Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma
Debora A Ledesma, Mario L Marques-Piubelli, Elsa Li-Ning-Tapia, et al.
Cancers
|
June 1, 2019
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy
Shakuntala H Mauzo, Michael T Tetzlaff, Denái R Milton, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 194) with videos related to
Sort By:
Page
of 20
Journal of Cutaneous Pathology
|
June 30, 2019
Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features
Michael T Tetzlaff, Sherry Tang, Taylor Duke, et al.
Cancers
|
November 6, 2019
Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity
Haider A Mejbel, Sri Krishna C Arudra, Dinesh Pradhan, et al.
Cancer
|
December 20, 2011
NRAS mutation status is an independent prognostic factor in metastatic melanoma
John A Jakob, Roland L Bassett, Chaan S Ng, et al.
Journal of Cutaneous Pathology
|
October 8, 2021
Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy
Riyad N H Seervai, Woo Cheal Cho, Emily Y Chu, et al.
Journal of Cutaneous Pathology
|
December 10, 2021
Severe de novo pustular psoriasiform immune-related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma
Riyad N H Seervai, Meghan Heberton, Woo Cheal Cho, et al.
Journal of Cutaneous Pathology
|
May 13, 2020
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma
Mario L Marques-Piubelli, Michael T Tetzlaff, Priyadharsini Nagarajan, et al.
Journal of Cutaneous Pathology
|
June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions
Wei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
Cells
|
March 13, 2024
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides
Mario L Marques-Piubelli, Jesus Navarrete, Debora A Ledesma, et al.
The American Journal of Dermatopathology
|
May 8, 2024
Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma
Debora A Ledesma, Mario L Marques-Piubelli, Elsa Li-Ning-Tapia, et al.
Cancers
|
June 1, 2019
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy
Shakuntala H Mauzo, Michael T Tetzlaff, Denái R Milton, et al.
Page
of 20